Firefighter Turnout Gear Lawsuits Belong in MDL With Other AFFF and PFAS Exposure Lawsuits, Judge Indicates
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Roblox Lawsuit Families are filing Roblox lawsuits after children were targeted by predators for grooming, sextortion, sexual abuse, or exploitation on the platform. Learn who qualifies, what cases allege, and how to file a confidential claim.
Dupixent Lawsuit Dupixent lawsuits are being investigated for patients who developed rare blood cancers such as cutaneous T-cell lymphoma (CTCL) after receiving injections, alleging that Sanofi and Regeneron failed to warn about the potential risks of immune suppression and delayed cancer diagnosis.
Tabletop Fire Pit Lawsuit Individuals who suffered severe burns, or families who lost a loved one in a tabletop fire pit explosion, may be eligible for financial compensation through a fire pit injury lawsuit.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
3M Expected To Face Years of Lawsuits Over PFAS Years After Ending Production of “Forever Chemical” in 2025 Even after 3M ends production of the toxic chemicals, it is likely to continue to face PFAS water contamination lawsuits for decades due to the persistent nature of the “forever chemicals” December 21, 2022 Irvin Jackson Add Your Comments In a long-anticipated announcement, 3M Company says it will stop producing toxic per- and polyfluoroalkyl substances (PFAS) by 2025, but the move will still leave the manufacturer exposed to years of liability exposure over adverse health effects and environmental damage caused by the “forever chemicals”, which are known to persist in the environment and build up in the human body. In a press release issued on December 20, 3M announced that it will “exit PFAS manufacturing” by the end of 2025. The company claims the decision was based on an evaluation of multiple factors, such as increasing regulation focused on eliminating PFAS from the environment. However, the move appears clearly related to the impending damages the company is likely to face from PFAS water contamination lawsuit payouts, which are being pursued by communities nationwide, as well as individuals diagnosed with ulcerative colitis, cancer and other injuries. PFAS “Forever Chemical” Concerns PFAS are a group of over 9,000 man-made chemicals that have been frequently used in consumer and industrial products to resist grease, oil, and water since the 1940’s. While they are widely found in products like non-stick pans, pizza boxes an other material, the chemicals have caused widespread water contamination problems from firefighting foam, which has been used to combat fuel based fires for decades, particularly at military bases, airports and other firefighter training locations. As a result of the harmful effects of the chemicals, 3M Company and many other manufacturers face hundreds of firefighting foam cancer lawsuits brought by former users, alleging that they were not adequately warned about the health risks of aqueous film-forming foam (AFFF) used by both military and civilian firefighters. In addition, a number of communities and local water suppliers have also filed lawsuits, particularly targeting 3M, over the costs associated with cleaning up the chemicals from drinking water. The company also faces water contamination lawsuits brought by individuals who lived near military bases and other areas with high levels of the chemicals in their tap water. Firefighting Foam Lawsuits Were you or a loved one exposed to toxic AFFF Chemicals? Lawyers are reviewing aqueous film forming foam (AFFF) lawsuits for firefighters, military personnel and individuals who developed cancer or other health issues from exposure to toxic firefighting foam chemicals. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Firefighting Foam Lawsuits Were you or a loved one exposed to toxic AFFF Chemicals? Lawyers are reviewing aqueous film forming foam (AFFF) lawsuits for firefighters, military personnel and individuals who developed cancer or other health issues from exposure to toxic firefighting foam chemicals. Learn More SEE IF YOU QUALIFY FOR COMPENSATION 3M says that by the end of 2025 it will discontinue the manufacture of all fluoropolymers, fluorinated fluids, and PFAS-based additives. The company pledges to help transition other manufacturers who purchase the chemicals away from those products, and will fulfill current contractual obligations while it transitions. The company also indicates it will work to discontinue the use of PFAS products across its portfolio within the same time frame. However, even in the announcement, 3M defended the safety of PFAS chemicals. “While PFAS can be safely made and used, we also see an opportunity to lead in a rapidly evolving external regulatory and business landscape to make the greatest impact for those we serve,” 3M’s Chairman and CEO, Mike Roman, said in the press release. “This action is another example of how we are positioning 3M for continued sustainable growth by optimizing our portfolio, innovating for our customers, and delivering long-term value for our shareholders.” 3M Firefighter Foam and PFAS Water Contamination Lawsuits Despite the move, critics note that 3M will continue to face thousands of lawsuits indicating its firefighting foam and other chemical products contributed to water contamination and adverse health problems nationwide. There are currently about 3,000 product liability lawsuits over toxic PFAS effects pending nationwide against 3M and a host of other companies, each involving similar allegations that the companies failed to warn about the long-term health risks from exposure to the chemicals. The number of claims is likely to continue to grow for decades, given the nature of PFAS, which earned the name “forever chemicals” due to their persistence in the environment, meaning they will likely continue to be a toxic threat to water supplies and human health for a long time to come, and 3M could be held liable for much of that as lawsuits continue to be filed for years. Given common questions of fact and law raised in lawsuits being filed against 3M Company, Dupont and other manufacturers of PFAS chemicals and fire safety equipment, consolidated pretrial proceedings have been established in the federal court system, where claims brought nationwide are all centralized before one judge in the U.S. District Court for the District of South Carolina, for coordinated discovery and a series of early trial dates to help gauge how juries are likely to respond to certain evidence and testimony that will be repeated throughout the litigation. Earlier this year, the Court selected a PFAS water contamination lawsuits for the first bellwether trial, which will go before a jury in 2023. While the outcome of the first trials will not be binding on firefighters or other plaintiffs, they will be closely watched and may influence future settlement negotiations over the PFAS cancer risks. Written by: Irvin Jackson Senior Legal Journalist & Contributing Editor Irvin Jackson is a senior investigative reporter at AboutLawsuits.com with more than 30 years of experience covering mass tort litigation, environmental policy, and consumer safety. He previously served as Associate Editor at Inside the EPA and contributes original reporting on product liability lawsuits, regulatory failures, and nationwide litigation trends. Tags: 3M, 3M Company, Cancer, Chemicals, Firefighter Foam, PFAS, Toxic Tort, Water Contamination Find Out If You Qualify for A AFFF Lawsuit Settlement More Firefighting Foam Lawsuit Stories Three AFFF Ulcerative Colitis Lawsuits Selected for Tier 2 Bellwether Trials September 16, 2025 Firefighter Turnout Gear Lawsuits Belong in MDL With Other AFFF and PFAS Exposure Lawsuits, Judge Indicates August 28, 2025 PFAS Water Contamination Map Shows States With Highest ‘Forever Chemicals’ August 22, 2025 0 Comments CommentsThis field is for validation purposes and should be left unchanged.Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA Term Δ MORE TOP STORIES Dupixent Cancer Risks Outlined in User Stories, as Evidence Mounts of T-Cell Lymphoma Link (Posted: today) Dupixent users are coming forward with accounts of devastating cancer diagnoses, saying the popular eczema drug masked early warning signs of cutaneous T-cell lymphoma. As the FDA investigates and the first lawsuit is filed, researchers warn Dupixent may unmask or accelerate hidden cancers, raising urgent questions about its long-term safety. MORE ABOUT: DUPIXENT LAWSUITDupixent Wrongful Death Lawsuit Filed Over T-Cell Lymphoma Diagnosis (10/02/2025)Dupixent Cutaneous T-Cell Lymphoma Warning Label Update Being Evaluated by FDA (09/15/2025)Dupixent T-Cell Lymphoma Lawsuits May Follow Recent Studies Linking Drug to Cancer Risks (09/04/2025) Lawsuits Over Vision Loss From Ozempic, Mounjaro Should Be Sent to New MDL Judge, Plaintiffs Argue (Posted: yesterday) Plaintiffs involved in GLP-1 vision loss lawsuits are calling for the litigation to be consolidated in New Jersey federal court, and not be bundled with existing stomach paralysis litigation. MORE ABOUT: OZEMPIC LAWSUITReports of ‘Ozempic Teeth’ Raise Concerns Over Dry Mouth Side Effects Linked to GLP-1s (10/03/2025)Study Raises New Questions Over Ozempic Hair Loss Risks (09/26/2025)Mounjaro Side Effects Led to Emergency Surgery, Lawsuit Alleges (09/24/2025) Over 1,300 Depo Shot Lawsuits Now Being Pursued by Women With Meningioma Tumors (Posted: 2 days ago) A federal judge has called for more coordination between state and federal courts handling Depo shot lawsuits claiming the contraceptive causes brain tumors. MORE ABOUT: DEPO-PROVERA LAWSUITDepo-Provera Brain Tumor Lawsuit Describes Left-Sided Numbness, Tingling Before Diagnosis (10/01/2025)Judge To Hear Depo-Provera Lawsuit Preemption Arguments on Monday (09/26/2025)Link Between Depo-Provera and Meningioma Brain Tumors Ignored by Pfizer, Plaintiffs Indicate (09/22/2025)
Firefighter Turnout Gear Lawsuits Belong in MDL With Other AFFF and PFAS Exposure Lawsuits, Judge Indicates August 28, 2025
Dupixent Cancer Risks Outlined in User Stories, as Evidence Mounts of T-Cell Lymphoma Link (Posted: today) Dupixent users are coming forward with accounts of devastating cancer diagnoses, saying the popular eczema drug masked early warning signs of cutaneous T-cell lymphoma. As the FDA investigates and the first lawsuit is filed, researchers warn Dupixent may unmask or accelerate hidden cancers, raising urgent questions about its long-term safety. MORE ABOUT: DUPIXENT LAWSUITDupixent Wrongful Death Lawsuit Filed Over T-Cell Lymphoma Diagnosis (10/02/2025)Dupixent Cutaneous T-Cell Lymphoma Warning Label Update Being Evaluated by FDA (09/15/2025)Dupixent T-Cell Lymphoma Lawsuits May Follow Recent Studies Linking Drug to Cancer Risks (09/04/2025)
Lawsuits Over Vision Loss From Ozempic, Mounjaro Should Be Sent to New MDL Judge, Plaintiffs Argue (Posted: yesterday) Plaintiffs involved in GLP-1 vision loss lawsuits are calling for the litigation to be consolidated in New Jersey federal court, and not be bundled with existing stomach paralysis litigation. MORE ABOUT: OZEMPIC LAWSUITReports of ‘Ozempic Teeth’ Raise Concerns Over Dry Mouth Side Effects Linked to GLP-1s (10/03/2025)Study Raises New Questions Over Ozempic Hair Loss Risks (09/26/2025)Mounjaro Side Effects Led to Emergency Surgery, Lawsuit Alleges (09/24/2025)
Over 1,300 Depo Shot Lawsuits Now Being Pursued by Women With Meningioma Tumors (Posted: 2 days ago) A federal judge has called for more coordination between state and federal courts handling Depo shot lawsuits claiming the contraceptive causes brain tumors. MORE ABOUT: DEPO-PROVERA LAWSUITDepo-Provera Brain Tumor Lawsuit Describes Left-Sided Numbness, Tingling Before Diagnosis (10/01/2025)Judge To Hear Depo-Provera Lawsuit Preemption Arguments on Monday (09/26/2025)Link Between Depo-Provera and Meningioma Brain Tumors Ignored by Pfizer, Plaintiffs Indicate (09/22/2025)